TheEdgeResearch
Home / Stocks / CATX

Perspective Therapeutics, Inc. (CATX)

AMEX Healthcare Medical - Devices
$0.75 ▼ -3.85%
Market Cap
$91.0M
Sector
Healthcare
Industry
Medical - Devices
Beta
1.99
52-Wk Range
0.7252-6.16
CEO
Johan Spoor
Country
US
Currency
USD

Perspective Therapeutics, Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Seattle, WA, US. The stock last traded at $0.75, down 3.85% on the session, giving a market capitalisation of $91.0M. On trailing twelve-month figures it carries a trailing P/E of -0.61, a net margin of -69439.0%. Its beta of 1.99 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-0.61
Price / Sales
514.28
Price / Book
0.31
EV / EBITDA
-0.44
Gross margin
-536.2%
Operating margin
-74402.8%
Net margin
-69439.0%
Return on equity
—
Debt / equity
0.01
Current ratio
5.18
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
New York Stock Exchange Arca
Employees
165
IPO date
2005-11-10
Headquarters
Seattle, WA, US
About Perspective Therapeutics, Inc.

Perspective Therapeutics, Inc., including its various operations, specializes in the comprehensive lifecycle – from development and manufacturing to sales and marketing – of radiopharmaceutical products and medical devices. These advanced solutions are designed to treat cancer and other serious malignant conditions, serving markets both within the United States and globally. A flagship product offered by the company is its CS-1 Cesium-131 brachytherapy seeds. This treatment is specifically utilized for a broad range of cancers, such as those impacting the prostate, brain, lung, head and neck regions, gynecological system, pelvic/abdominal areas, and colorectal tissues. The company distributes its products to medical facilities and physician practices equipped with surgical capabilities. The entity originally operated under the name Isoray, Inc., before officially adopting the name Perspective Therapeutics, Inc. in February 2022. Founded in 1998, the company maintains its corporate headquarters in Richland, Washington.

Comparable companies

Perspective Therapeutics, Inc. is most often compared with the following Healthcare names:

ARAYDCTHITOCNVCRSRTSTLSI
More research on CATX
CATX technical analysis CATX TheEdge Score Compare against peers
Open full interactive analysis & DCF →